Clik here to view.
Research round-up: AAIC Day Two
Today was the second day of the Alzheimer’s Association International Conference 2014 in Copenhagen, where thousands of dementia researchers have gathered to discuss their latest results. Here is a...
View ArticleIn the news: B vitamins and Alzheimer’s disease
A new analysis of several clinical trials has drawn a conclusion that will dismay many: taking B vitamins does not slow the decline in memory and thinking skills that comes with age. The results...
View ArticleClik here to view.
Happy birthday dementiablog
Today is the the first anniversary of the Alzheimer’s Research UK Blog site. In that time it has become the place to find out the latest views on the impact and science of dementia. Big names What a...
View ArticleClik here to view.
My friends didn’t believe me when I told them I had Alzheimer’s disease.
My friends didn’t believe me when I told them I had Alzheimer’s disease. At the age of 39, it just doesn’t make sense to people. I’m ex-army, I’ve travelled the world and I’m fighting fit – how can I...
View ArticleClik here to view.
How many people develop dementia in their 30s?
How many people develop dementia in their 30s? You might have read in the news today, the story of Chris Graham, told at the age of 35 that he was going to develop Alzheimer’s. Chris’ brother is in the...
View ArticleClik here to view.
Why a diabetes drug may offer potential treatment for Alzheimer’s disease
You may have seen in the news recently the announcement that a drug commonly used to treat type 2 diabetes is to be tested in a clinical trial for Alzheimer’s disease. The study led by scientists at...
View ArticleClik here to view.
Solanezumab: Is the first disease-modifying treatment for Alzheimer’s on the...
We’re hearing in the news that a new treatment designed to slow Alzheimer’s has shown benefit in one of the final stages of testing in people. The drug is called solanezumab and the results were...
View ArticleClik here to view.
Dementia: it’s not all about Alzheimer’s or memory
It’s a common misconception that dementia is all about Alzheimer’s and that it’s all about memory loss. Alzheimer’s may be the most common cause of dementia and memory loss one of the most common...
View ArticleClik here to view.
In the news: What is healthy ageing and how do we know we’re doing it?
The UK population is ageing. In the middle of last year, the Office of National Statistics reported that the UK population was the oldest it had ever been. Around the same time, the papers reported...
View ArticleIn the news: Could Alzheimer’s proteins be passed between people?
In the news today, we’re hearing about a UK research study that has suggested the hallmark Alzheimer’s protein, amyloid, could have been passed between people in historic treatments with human-derived...
View ArticleClik here to view.
Dementia in the future: what’s in store for our children?
A new analysis has estimated that for every child born this year, one in three can be expected to develop dementia during their lifetime. The finding is revealed on World Alzheimer’s Day, a date that...
View ArticleClik here to view.
Pogo sticks, trial results and ‘transmissible Alzheimer’s’ – top 10 headlines...
It’s been a busy 12 months for the Alzheimer’s Research UK press team, with dementia seemingly never far from the headlines. We work hard to make sure dementia research and our amazing fundraisers and...
View ArticleClik here to view.
Help defeat dementia using only your thumb
We’ve blogged before about how attitudes towards dementia, and our scientific understanding, have been perhaps a generation behind other health areas, like cancer or heart disease. What we’re working...
View ArticleClik here to view.
The latest generation of dementia research
As Dementia Awareness Week approaches, BBC Horizon has thrown a spotlight onto dementia research with their latest programme featuring recent advances in the field. One of the studies discussed in this...
View ArticleClik here to view.
EU membership and dementia research
In 1950, six nations made a deal to tie their countries together politically and economically to try to prevent another war breaking out in Europe. The UK joined them in 1973, during the first wave of...
View ArticleSilver lining for first anti-tau Alzheimer’s treatment in phase III?
Findings were reported today from the first phase III anti-tau drug in people with mild-to-moderate Alzheimer’s. The drug, called LMTM, was being tested in a 15-month double-blind, controlled trial in...
View ArticleClik here to view.
Behind the headlines: what’s the real story for LMTX?
The UK public woke up this morning to a series of headlines about phase III trial results of a potential Alzheimer’s drug called LMTX (also known as LMTM). The Times (£) placed their report on the...
View ArticleClik here to view.
In the news: Aducanumab – new Alzheimer’s trial results announced
With 850,000 people currently living with dementia in the UK, and this number set to rise to over one million by 2025, urgency is building around dementia research and the hunt for new treatments that...
View ArticleClik here to view.
One important myth to overturn another
Around 18 months ago, Alzheimer’s Research UK launched its first-ever awareness advertising campaign, with an arresting and urgent film designed to shake society by the lapels in how it thinks about...
View ArticleClik here to view.
UK’s biggest dementia research endeavour starts to take shape
Today we’re proud to share with you the news that world-renowned Belgian scientist Prof Bart De Strooper will take the helm of the UK Dementia Research Institute (DRI), a multi-centre national...
View Article